Mqs Management LLC Ironwood Pharmaceuticals Inc Transaction History

Mqs Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $10,178 - $13,328	-1,158 Reduced 3.98%	27,908 $319,000
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $239,794 - $329,899	29,066 New	29,066 $279,000
Q3 2022 Nov 09, 2022	BUY	$10.14 - $12.38 $91,746 - $112,014	9,048 Added 77.46%	20,729 $215,000
Q2 2022 Aug 05, 2022	BUY	$11.05 - $12.72 $129,075 - $148,582	11,681 New	11,681 $135,000

232

163M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $334M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.